Week 3 counseling points

0.0(0)
Studied by 0 people
call kaiCall Kai
Locked
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/10

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 12:39 PM on 9/3/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai
Chat

No analytics yet

Send a link to your students to track their progress

11 Terms

1
New cards

dopamine

  • Warning(s): Vasopressors are vesicants; central access is preferred for prolonged administration. If administered peripherally, closely monitor the IV site for extravasation.

  • Note(s): MOA is dose dependent


2
New cards

epinephrine

  • Warning(s): Vasopressors are vesicants; central access is preferred for prolonged administration. If administered peripherally, closely monitor the IV site for extravasation.

  • Notes: Epi for IV push is 0.1 mg/mL, Epi for IM injection and compounding IV products is 1 mg/mL


3
New cards

norepinephrine

  • Warning(s): Vasopressors are vesicants; central access is preferred for prolonged administration. If administered peripherally, closely monitor the IV site for extravasation.


4
New cards

phenylephrine

  • Warning(s): Vasopressors are vesicants; central access is preferred for prolonged administration. If administered peripherally, closely monitor the IV site for extravasation.


5
New cards

vasopressin

  • Warning(s): Vasopressors are vesicants; central access is preferred for prolonged administration. If administered peripherally, closely monitor the IV site for extravasation.

  • Note(s): Known as arginine vasopressin (AVP) and antidiuretic hormone (ADH)


6
New cards

epoprostenol

  • Indication(s): Pulmonary arterial hypertension.

  • Note(s): Very potent vasodilator. Continuous IV infusion, avoid interruptions and sudden large dose reductions. Protect from light during infusion.


7
New cards

treprostinil

  • Indication(s): Pulmonary arterial hypertension

  • Note(s): Very potent vasodilator. Continuous IV infusion, avoid interruptions and sudden large dose reductions.


8
New cards

eptifibatide

Side effect(s): Bleeding, thrombocytopenia

9
New cards

eptifibatide

Side effect(s): Bleeding, thrombocytopenia

10
New cards

alteplase

Indication(s):

Activase- Acute ischemic stroke, pulmonary embolism, ST-elevation myocardial infarction (STEMI)

Cathflo Activase- IV line clearance

Contraindication(s): Active internal bleed, history of recent stroke, severe uncontrolled hypertension (BP cutoff >185/110mmHg), glucose <50

11
New cards

tenecteplase

  • Indication(s): ST-elevation myocardial infarction (STEMI), acute ischemic stroke in adults

  • Contraindication(s): Active internal bleed, history of recent stroke, severe uncontrolled hypertension (BP cutoff >185/110mmHg)